Extension Study of Patients With Infantile-Onset Pompe Disease Who Were Previously Enrolled in Protocol AGLU01602

Clinical trial NCT00125879 · COMPLETED

Trial details

NCT number: NCT00125879
Sponsor: Genzyme, a Sanofi Company
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Glycogen Storage Disease Type II

Start date: 2005-06-01
Primary completion: 2006-06-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.